Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies

European Journal of Medicinal Chemistry
Marco MiglioreRita Scarpelli

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) exert their pharmacological effects by inhibiting cyclooxygenase (COX)-1 and COX-2. Though widely prescribed for pain and inflammation, these agents have limited utility in chronic diseases due to serious mechanism-based adverse events such as gastrointestinal damage. Concomitant blockade of fatty acid amide hydrolase (FAAH) enhances the therapeutic effects of the NSAIDs while attenuating their propensity to cause gastrointestinal injury. This favorable interaction is attributed to the accumulation of protective FAAH substrates, such as the endocannabinoid anandamide, and suggests that agents simultaneously targeting COX and FAAH might provide an innovative strategy to combat pain and inflammation with reduced side effects. Here, we describe the rational design and structure-active relationship (SAR) properties of the first class of potent multitarget FAAH-COX inhibitors. A focused SAR exploration around the prototype 10r (ARN2508) led to the identification of achiral (18b) as well as racemic (29a-c and 29e) analogs. Absolute configurational assignment and pharmacological evaluation of single enantiomers of 10r are also presented. (S)-(+)-10r is the first highly potent and selectiv...Continue Reading

References

Jan 1, 1991·Journal of Clinical Gastroenterology·D E Wilson
Mar 26, 1999·Bioorganic & Medicinal Chemistry Letters·C I BaylyM D Percival
Jul 18, 2002·Nature Reviews. Drug Discovery·John L WallaceStefano Fiorucci
May 28, 2003·European Journal of Medicinal Chemistry·Maria Teresa CoccoOmar Cauli
Apr 16, 2004·The Journal of Clinical Investigation·Federico MassaBeat Lutz
Feb 18, 2006·Nature Reviews. Drug Discovery·Jane A Mitchell, Timothy D Warner
Feb 24, 2006·Journal of the American Chemical Society·Gerhard Wider, Lars Dreier
Sep 14, 2006·JAMA : the Journal of the American Medical Association·Jingjing ZhangYiqing Song
Apr 24, 2007·Pain·Margarita SuardíazFernando Rodríguez de Fonseca
Sep 22, 2007·Trends in Pharmacological Sciences·John L Wallace
Feb 26, 2008·Journal of Medicinal Chemistry·Loretta LazzaratoEnnio Ongini
Apr 26, 2008·Nature Reviews. Immunology·Charles N SerhanThomas E Van Dyke
Nov 6, 2008·Journal of Medicinal Chemistry·Mark Seierstad, J Guy Breitenbucher
Jan 2, 2009·The Journal of Pharmacology and Experimental Therapeutics·Pattipati S NaiduAron H Lichtman
Feb 5, 2010·British Journal of Pharmacology·John L WallaceGiuseppe Cirino
Sep 21, 2010·Nature Neuroscience·Jason R ClapperDaniele Piomelli
Apr 22, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Emanuela Ricciotti, Garret A FitzGerald
Sep 21, 2011·Nature Chemical Biology
Jan 10, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Christopher J FowlerValentina Onnis
Mar 17, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Oscar SassoDaniele Piomelli
Aug 4, 2012·ACS Chemical Neuroscience·Fabiana Piscitelli, Vincenzo Di Marzo
Sep 18, 2012·ACS Medicinal Chemistry Letters·Matthew A WindsorLawrence J Marnett
Oct 2, 2012·Annual Review of Pharmacology and Toxicology·Christophe Morisseau, Bruce D Hammock

❮ Previous
Next ❯

Citations

Aug 10, 2016·Annals of the New York Academy of Sciences·Carl J LaceyNed D Heindel
Aug 18, 2018·Nature Reviews. Drug Discovery·Vincenzo Di Marzo
Mar 24, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Alessandro DeplanoValentina Onnis
Apr 16, 2020·Expert Opinion on Drug Discovery·Domenico FazioMauro Maccarrone
Jan 13, 2018·The Journal of Biological Chemistry·Michael C GoodmanLawrence J Marnett
Feb 28, 2017·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A Fabisiak, J Fichna
Jan 17, 2020·European Journal of Medicinal Chemistry·Rati Kailash Prasad Tripathi
Jan 26, 2018·Bioorganic & Medicinal Chemistry Letters·Sean D KodaniBruce D Hammock
Feb 5, 2019·Biochimie·Sean D Kodani, Christophe Morisseau
Nov 30, 2018·Neurochemistry International·Fernanda Regina HamannMaribel Antonello Rubin
Feb 15, 2019·Journal of Chemical Information and Modeling·Zijian QinAixia Yan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.